Our paper addresses this controversy, and we demonstrate that Phf6 loss accelerates AML in a broadly relevant model and that it does so by increasing the frequency and persistence of leukemic stem cells, a finding that is harmonious with the known role of Phf6 as a repressor of HSC self-renewal. The gene discussed is PHF6; the disease is acute myeloid leukemia.